Walgreens/$WBA
13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX
About Walgreens
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Ticker
$WBA
Sector
Primary listing
Industry
Consumer Staples Distribution & Retail
Headquarters
Employees
252,500
ISIN
US9314271084
Walgreens Metrics
BasicAdvanced
$9.9B
-
-$6.69
0.64
$0.50
8.78%
Price and volume
Market cap
$9.9B
Beta
0.64
52-week high
$16.25
52-week low
$8.08
Average daily volume
9.5M
Dividend rate
$0.50
Financial strength
Current ratio
0.611
Quick ratio
0.266
Long term debt to equity
375.262
Total debt to equity
415.24
Interest coverage (TTM)
-1.21%
Profitability
EBITDA (TTM)
1,326
Gross margin (TTM)
17.39%
Net profit margin (TTM)
-3.80%
Operating margin (TTM)
-0.48%
Effective tax rate (TTM)
-35.33%
Revenue per employee (TTM)
$600,000
Management effectiveness
Return on assets (TTM)
-0.88%
Return on equity (TTM)
-66.20%
Valuation
Price to revenue (TTM)
0.065
Price to book
1.38
Price to tangible book (TTM)
-0.64
Price to free cash flow (TTM)
17.229
Free cash flow yield (TTM)
5.80%
Free cash flow per share (TTM)
66.11%
Dividend yield (TTM)
4.39%
Forward dividend yield
8.78%
Growth
Revenue change (TTM)
5.08%
Earnings per share change (TTM)
-4.39%
3-year revenue growth (CAGR)
3.78%
10-year revenue growth (CAGR)
6.03%
3-year earnings per share growth (CAGR)
-2.66%
10-year earnings per share growth (CAGR)
6.89%
3-year dividend per share growth (CAGR)
-26.64%
10-year dividend per share growth (CAGR)
-5.55%
What the Analysts think about Walgreens
Analyst ratings (Buy, Hold, Sell) for Walgreens stock.
Bulls say / Bears say
Walgreens' second-quarter profit exceeded Wall Street expectations, reporting adjusted earnings of 63 cents per share against the anticipated 53 cents, indicating effective cost-cutting and operational improvements. (reuters.com)
The company's U.S. retail pharmacy unit reported sales of $30.38 billion for the quarter ending February 28, surpassing estimates of $29.67 billion, reflecting strong consumer demand. (reuters.com)
CEO Tim Wentworth's turnaround strategy, including closing underperforming stores and a $1 billion cost-cutting initiative, has started to yield positive financial results. (reuters.com)
Walgreens has suspended its quarterly cash dividend to address restructuring needs and litigation costs, which may signal financial strain and impact investor confidence. (reuters.com)
The company faces potential civil penalties from a U.S. Department of Justice lawsuit for allegedly filling unlawful prescriptions, posing significant legal and financial risks. (reuters.com)
Analysts have downgraded Walgreens' stock, with RBC Capital lowering the price target from $22 to $13, citing weaker-than-expected Q3 results and ongoing retail and pharmacy headwinds. (thestreet.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jun 2025.
Walgreens Financial Performance
Revenues and expenses
Walgreens Earnings Performance
Company profitability
Walgreens News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Walgreens stock?
Walgreens (WBA) has a market cap of $9.9B as of June 20, 2025.
What is the P/E ratio for Walgreens stock?
The price to earnings (P/E) ratio for Walgreens (WBA) stock is 0 as of June 20, 2025.
Does Walgreens stock pay dividends?
Yes, the Walgreens (WBA) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $0.5 and the yield is 8.78%. Walgreens has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Walgreens dividend payment date?
The next Walgreens (WBA) dividend payment date is unconfirmed.
What is the beta indicator for Walgreens?
Walgreens (WBA) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
